If you are a new applicant or existing grantee and have been impacted by COVID-19 or a natural disaster, please contact your Customer Service Manager or one of the agents at our Contact Centre to discuss your circumstances and how we can assist you.

You can find more information and support on our Emergency management page.

MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity

This grant provides researchers with funding to improve the safe and effective use of medicines

The grant is no longer available

What you get?

Up to $2.5 million to support medical research and medical innovation projects.

Who is this for?

Eligible organisations seeking to improve medical innovation.


The 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity is part of the Medical Research Future Fund (MRFF) and the Preventive and Public Health Research Initiative.

It will support research to

  • test innovative public health approaches
  • identify innovative approaches to treat and manage chronic and complex diseases
  • improve the quality and cost-effectiveness of preventive healthcare interventions

It will provide grants to support medical research and innovation projects that create or adapt:

  • technologies
  • mechanisms
  • approaches

Projects should aim to improve medicine use and medicine intervention by pharmacists in primary health and transitions of care. They should target improvements to quality, safety and effectiveness. The projects should also align with relevant peak or representative bodies to help national implementation.

Intended outcomes

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians. 

It will promote the safe and effective use of medicines, particularly in high-risk groups and settings such as:

  • the elderly
  • people with complex chronic diseases
  • rural and remote communities
  • Aboriginal and Torres Strait Islander peoples
  • culturally and linguistically diverse people and communities
  • aged care facilities

It also aims to reduce adverse drug events and medicine-related hospital admissions.


What are the eligibility criteria?

To be eligible you must:

  • have an Australian business number (ABN)
  • be incorporated in Australia

You must also be one of the following entities:

  • a medical research institute
  • a university 
  • a corporate Commonwealth entity 
  • a corporation (including businesses and not for profits)
  • a state or territory government
  • a state or territory government entity

We encourage joint applications provided you have a lead organisation who is the main driver of the project and is eligible to apply.

We can only accept applications where you can provide:

  • details of your nominated Chief Investigator A (CIA), the person who will take the lead role in conducting the project
  • details of all members of your research team are listed as Chief Investigators (CIs)
  • evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
  • letters of support from each project partner, where applicable


How do you apply?

The MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity is closed to applications.

Need help?

  • Let us answer your question via phone, email or webchat. And if we can't help, we'll put you in touch with someone who can.

  • Monday – Friday, 8am – 8pm across Australia